UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2003
ARENA PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
|
DELAWARE |
|
000-31161 |
|
23-2908305 |
|
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
|
|
||||
|
6166 Nancy Ridge Drive, San Diego, California 92121 |
||||
|
(Address of Principal Executive Offices) (Zip Code) |
||||
|
|
||||
|
(858) 453-7200 |
||||
|
(Registrant’s telephone number, including area code) |
||||
|
|
||||
|
N/A |
||||
|
(Former Name or Former Address, if Changed Since Last Report) |
||||
Item 7. Financial Statements and Exhibits.
|
(c) |
|
Exhibits. |
|
|
|
|
|
|
|
|
|
99.1 |
Press release issued October 22, 2003, announcing financial results for the quarterly period ended September 30, 2003. |
Item 12. Results of Operations and Financial Condition.
On October 22, 2003, Arena Pharmaceuticals, Inc. issued a press release announcing its financial results for the quarterly period ended September 30, 2003. A copy of the press release is attached hereto as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: October 22, 2003 |
|
Arena Pharmaceuticals, Inc., |
||
|
|
|
a Delaware corporation |
||
|
|
|
|
||
|
|
|
|
||
|
|
|
By: |
/s/ Jack Lief |
|
|
|
|
|
Jack Lief |
|
|
|
|
|
President & Chief Executive Officer |
|
2
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press release issued October 22, 2003, announcing financial results for the quarterly period ended September 30, 2003. |
3